Medtronic announces real-world data on inpen™ and extended infusion set* pivotal trial data at the american diabetes association 81st scientific sessions

Dublin, june 23, 2021 /prnewswire/ -- medtronic plc (nyse: mdt), the global leader in medical technology, today announced its participation at the american diabetes association (ada) 81th scientific sessions virtual meeting, june 25-29, 2021. medtronic will be participating in this year's ada virtual sessions with seven data presentations, a product theater, two on-demand learning sessions, and a virtual exhibit.
MDT Ratings Summary
MDT Quant Ranking